International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
1,696,948
Fulltext
1,152,299
PDF
544,649

Articles	Fulltext downloads	PDF downloads	Total downloads
Short Communication Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	34,522	3,830	38,352
Review Article Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023	28,262	2,489	30,751
Editorial Challenging conventional wisdom in molecular oncology: New perspectives Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023	26,765	2,355	29,120
Original Article Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023	26,590	2,367	28,957
Short Communication Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	25,142	2,984	28,126
Case Report *Long-term efficacy of osimertinib in de novo* exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India** Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023	24,082	2,388	26,470
Review Article Molecular oncology and the role of artificial intelligence in advancing cancer treatment Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023	22,717	1,772	24,489
Editorial Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024	17,810	2,798	20,608
Review Article Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024	17,908	2,551	20,459
Original Article Spectrum of lymphomas in India Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023	17,486	1,799	19,285
Review Article High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024	16,523	2,281	18,804
News Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	15,928	2,833	18,761
Review Article Understanding immunotherapy and CAR-T-cells: A narrative review Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023	16,602	2,112	18,714
Review Article Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	13,490	4,940	18,430
Case Report Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	12,599	5,651	18,250
Case Report Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023	14,920	2,337	17,257
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	14,279	2,309	16,588
Cardio Oncology with ACOS Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	12,219	4,311	16,530
Review Article Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022	14,304	2,187	16,491
New Drug Update Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	14,115	2,206	16,321
Review Article Combination of PARPi and anti-PD-L1 therapies in ovarian cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022	14,763	1,398	16,161
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	12,430	3,546	15,976
Review Article Potential therapeutic molecular targets for better outcomes for patients with lung cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022	14,884	1,091	15,975
Original Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	11,369	4,280	15,649
Review Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	10,883	4,581	15,464
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	10,764	4,413	15,177
Case Series Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	12,356	2,466	14,822
Review Article Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	9,321	5,312	14,633
Case Report L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023	12,841	1,586	14,427
Review Article The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	11,800	2,571	14,371
Review Article Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	10,865	3,417	14,282
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	9,606	4,435	14,041
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	11,216	2,755	13,971
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	10,158	3,639	13,797
Case Report Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	11,029	2,760	13,789
Case Report Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	8,667	5,059	13,726
Editorial Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	6,612	7,107	13,719
Case Report Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	11,176	2,225	13,401
Review Article The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	10,045	3,302	13,347
Conference Review 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	11,290	2,053	13,343
Brief Commentary ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	10,671	2,660	13,331
Erratum Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	11,551	1,572	13,123
Brief Commentary Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	10,208	2,674	12,882
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	8,789	4,069	12,858
Review Article Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	7,945	4,715	12,660
Letter to editor Letter to editor Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022	8,292	4,356	12,648
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	7,075	5,562	12,637
Case Report Metastatic endometrial carcinoma responsive to pembrolizumab Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020	7,189	5,343	12,532
Review Article *Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ* hybridization and Immunohistochemistry: A meta-analysis with systematic review** Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019	6,469	5,969	12,438
Original Article Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2021	8,549	3,344	11,893

Most Viewed Articles

Driver mutations in oncogenesis

Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes

Challenging conventional wisdom in molecular oncology: New perspectives

Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India

Molecular oncology and the role of artificial intelligence in advancing cancer treatment

Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer

Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article

Spectrum of lymphomas in India

High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective

Editorial board tribute to Dr. Amit Verma

Understanding immunotherapy and CAR-T-cells: A narrative review

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Combination of PARPi and anti-PD-L1 therapies in ovarian cancer

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Potential therapeutic molecular targets for better outcomes for patients with lung cancer

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Immune dynamics of SARS-CoV-2 virus evolution

Advances in immunotherapy for metastatic esophageal cancer

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Immuno-oncological era of breast cancer: A progressive path to better treatment

L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

Immuno-oncology of differentiated thyroid cancer

Breast cancer prognostic tools: A promising Indian option

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

A compendium of population wide DNA methylation profile for oral cancer in India

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

Nanobytes

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

The Cancer Genomic Atlas – “TO CONQUER CANCER”

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

Molecular genetics changes in gallbladder carcinoma

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

Letter to editor

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

Metastatic endometrial carcinoma responsive to pembrolizumab

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region

**Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India**

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

**Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review**